OPEN END TURBO OPTIONSSCHEIN SHORT - ELI LILLY & CO | Market Closed - BOERSE MUENCHEN 11:57:19 05/07/2024 pm IST | ||
| 12.78 EUR | -10.06% |
|
| Current month | -2.52% | ||
| 1 month | -36.39% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
| Date | Price | Change |
|---|---|---|
| 05/24/05 | 12.78 | -10.06% |
| 04/24/04 | 14.21 | -5.89% |
| 03/24/03 | 15.1 | +12.27% |
| 02/24/02 | 13.45 | +1.36% |
| 01/24/01 | 13.27 | +1.22% |
Real-time BOERSE MUENCHEN
Last update July 05, 2024 at 11:57 pm IST
More quotesStatic data
| Product type | Knock-Out ohne Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | Goldman Sachs |
| WKN | GQ9F8A |
| ISIN | DE000GQ9F8A6 |
| Date issued | 19/02/2024 |
| Strike | 1,053 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 24.99 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 31.07 € |
|---|---|
| Lowest since issue | 12.78 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
914.6
USD
Average target price
870.3
USD
Spread / Average Target
-4.84%
- Stock Market
- Certificates
- Certificat
